ALB and cancer: The annual sales of AmBisome and Doxil both reach hundreds of millions of dollars.[141, 142] In addition, iron oxide nanoparticles (Feraheme), albumin nanoparticles (Abraxane) and other materials are also widely used in clinical practice.[143, 144] Therefore, we remain optimistic about the potential of nanomedicines in cancer treatment.